Evofem Biosciences (EVFM) Competitors $0.0091 0.00 (-2.15%) As of 08/1/2025 03:37 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EVFM vs. CMND, RDHL, DRMA, VRAX, TTNP, ALBT, SPRC, NBY, EVAX, and CANFShould you be buying Evofem Biosciences stock or one of its competitors? The main competitors of Evofem Biosciences include Clearmind Medicine (CMND), Redhill Biopharma (RDHL), Dermata Therapeutics (DRMA), Virax Biolabs Group (VRAX), Titan Pharmaceuticals (TTNP), Avalon GloboCare (ALBT), SciSparc (SPRC), NovaBay Pharmaceuticals (NBY), Evaxion A/S (EVAX), and Can-Fite BioPharma (CANF). These companies are all part of the "pharmaceutical products" industry. Evofem Biosciences vs. Its Competitors Clearmind Medicine Redhill Biopharma Dermata Therapeutics Virax Biolabs Group Titan Pharmaceuticals Avalon GloboCare SciSparc NovaBay Pharmaceuticals Evaxion A/S Can-Fite BioPharma Clearmind Medicine (NASDAQ:CMND) and Evofem Biosciences (NASDAQ:EVFM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk. Does the media favor CMND or EVFM? In the previous week, Clearmind Medicine had 1 more articles in the media than Evofem Biosciences. MarketBeat recorded 2 mentions for Clearmind Medicine and 1 mentions for Evofem Biosciences. Clearmind Medicine's average media sentiment score of -0.50 beat Evofem Biosciences' score of -1.00 indicating that Clearmind Medicine is being referred to more favorably in the media. Company Overall Sentiment Clearmind Medicine Negative Evofem Biosciences Negative Which has higher earnings and valuation, CMND or EVFM? Evofem Biosciences has higher revenue and earnings than Clearmind Medicine. Clearmind Medicine is trading at a lower price-to-earnings ratio than Evofem Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearmind MedicineN/AN/A-$5.26M-$1.10-0.88Evofem Biosciences$11.39M0.09$52.98M-$0.05-0.18 Which has more volatility & risk, CMND or EVFM? Clearmind Medicine has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Evofem Biosciences has a beta of -0.92, suggesting that its stock price is 192% less volatile than the S&P 500. Do institutionals & insiders hold more shares of CMND or EVFM? 96.1% of Clearmind Medicine shares are owned by institutional investors. Comparatively, 0.2% of Evofem Biosciences shares are owned by institutional investors. 0.2% of Evofem Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is CMND or EVFM more profitable? Clearmind Medicine has a net margin of 0.00% compared to Evofem Biosciences' net margin of -46.42%. Evofem Biosciences' return on equity of -91.97% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Clearmind MedicineN/A -164.79% -71.12% Evofem Biosciences -46.42%-91.97%-61.93% SummaryEvofem Biosciences beats Clearmind Medicine on 7 of the 12 factors compared between the two stocks. Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EVFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVFM vs. The Competition Export to ExcelMetricEvofem BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.10M$771.23M$5.49B$9.52BDividend YieldN/A4.84%4.73%4.09%P/E Ratio-0.011.3428.7823.81Price / Sales0.0925.68372.2066.04Price / CashN/A19.5635.4557.96Price / Book0.006.768.275.54Net Income$52.98M-$3.67M$3.25B$259.28M7 Day PerformanceN/A-4.45%-3.70%-4.64%1 Month PerformanceN/A0.35%4.34%4.41%1 Year PerformanceN/A16.03%25.90%17.95% Evofem Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVFMEvofem Biosciences0.756 of 5 stars$0.01-2.2%N/A-9.0%$1.10M$11.39M-0.01120Short Interest ↑CMNDClearmind Medicine0.1896 of 5 stars$1.16+16.0%N/A-35.3%$4.27MN/A-1.05N/AShort Interest ↑Gap UpHigh Trading VolumeRDHLRedhill BiopharmaN/A$2.35+26.3%N/A-99.7%$4.27M$8.04M0.00210High Trading VolumeDRMADermata Therapeutics0.576 of 5 stars$0.69+6.2%$3.00+331.7%+160.1%$4.17MN/A-0.048Upcoming EarningsShort Interest ↑VRAXVirax Biolabs Group2.5756 of 5 stars$1.11+15.6%$3.00+170.3%-26.5%$4.17M$10K0.005Gap UpTTNPTitan Pharmaceuticals0.2796 of 5 stars$4.54+1.2%N/A-33.4%$4.10M$180K0.0010ALBTAvalon GloboCare1.085 of 5 stars$2.32+7.4%N/A-55.4%$4.09M$1.33M-0.125Positive NewsShort Interest ↑Gap UpSPRCSciSparc0.3371 of 5 stars$7.99+6.0%N/A-34.7%$4.03M$1.31M0.004News CoverageShort Interest ↑NBYNovaBay Pharmaceuticals1.6118 of 5 stars$0.65-1.6%$0.85+30.3%+10.9%$3.80M$9.78M-0.0130Gap DownEVAXEvaxion A/S1.8229 of 5 stars$2.57-2.3%$10.00+289.1%-82.1%$3.69M$3.34M-2.2260Short Interest ↑CANFCan-Fite BioPharma3.067 of 5 stars$1.04-0.5%$14.00+1,252.7%-78.6%$3.66M$674K-0.588Analyst ForecastGap Up Related Companies and Tools Related Companies Clearmind Medicine Alternatives Redhill Biopharma Alternatives Dermata Therapeutics Alternatives Virax Biolabs Group Alternatives Titan Pharmaceuticals Alternatives Avalon GloboCare Alternatives SciSparc Alternatives NovaBay Pharmaceuticals Alternatives Evaxion A/S Alternatives Can-Fite BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVFM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVFM Stock Alerts